Nghiên cứu & Báo cáo
30 thg 8, 2026•1 phút đọc
Artificial Sweeteners May Increase HbA1c and Insulin Levels, Study Finds
A large analysis of 21 randomized controlled trials suggests that artificial sweeteners could worsen blood‑sugar control, raising HbA1c and insulin levels.
Nghiên cứu & Báo cáo
30 thg 8, 2026•1 phút đọc
Acelra Presents Phase 1 Results of ACL-508 at NLA Conference
Acelra, the new‑drug subsidiary of Jonggeundang, reported Phase 1 data for its CETP inhibitor ACL‑508, aimed at lowering LDL‑C and raising HDL‑C, at the NLA annual meeting in Chicago.
Nghiên cứu & Báo cáo
30 thg 8, 2026•1 phút đọc
Nordic Walking Significantly Improves Moderate to Severe Depression Symptoms, Study Finds
A randomized trial of 64 adults shows Nordic walking reduces depressive symptoms within five weeks, especially in severe cases.
Nghiên cứu & Báo cáo
30 thg 8, 2026•1 phút đọc
Huons Initiates Phase 2 Trial of Peptide Dry‑Eye Drug HUC1‑394 with First Patient Enrolled
Huons reported first patient enrollment in the Phase 2 study of its peptide‑based dry‑eye candidate HUC1‑394, targeting 150 patients across Korean hospitals.
Nghiên cứu & Báo cáo
30 thg 8, 2026•1 phút đọc
Immunomic Therapeutics Completes First Patient Dosing in Phase 1 Trial of ITI-9001 for Japanese Cedar Pollen Allergy
Immunomic Therapeutics reported first patient dosing in a Phase 1 trial of ITI-9001, a Japanese cedar pollen allergy vaccine, with no safety issues observed.